KD Logo

Zevra Therapeutics Inc [ZVRA] Director makes an insider purchase of 300 shares worth 2352.0.

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Zevra Therapeutics Inc shares valued at $2,352 were purchased by Watton Corey Michael on Mar 28 ’25. At $7.84 per share, Watton Corey Michael acquired 300 shares. The insider’s holdings grew to 1,800 shares worth approximately $13788.0 following the completion of this transaction.

Also, Bode John B purchased 10,000 shares, netting a total of over 79,624 in proceeds. Following the buying of shares at $7.96 each, the insider now holds 40,000 shares.

Before that, Sangiovanni Timothy J. had sold 3,000 shares from its account. In a trade valued at $23,588, the SVP, Finance & Corp Controller traded Zevra Therapeutics Inc shares for $7.86 each. Upon closing the transaction, the insider’s holdings decreased to 3,000 shares, worth approximately $0.13 million.

Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in early October. As of September 24, 2024, Maxim Group has reiterated its “Buy” rating for ZVRA. Earlier on September 24, 2024, JMP Securities initiated its rating. Their recommendation was “a Mkt outperform” for ZVRA stock.

Analyzing ZVRA Stock Performance

During the last five days, there has been a drop of approximately -2.42%. Over the course of the year, Zevra Therapeutics Inc shares have dropped approximately -8.15%. Shares of the company reached a 52-week high of $8.95 on 01/03/25 and a 52-week low of $7.19 on 04/02/25. A 50-day SMA is recorded $7.86, while a 200-day SMA reached $7.58.

Support And Resistance Levels for Zevra Therapeutics Inc (ZVRA)

According to the 24-hour chart, there is a support level at 7.34, which, if violated, would cause prices to drop to 7.02. In the upper region, resistance lies at 7.83. The next price resistance is at 8.00. RSI (Relative Strength Index) is 45.72 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.45, which suggests the price will decrease in the coming days. Percent R is at 63.97%, indicating low price movement. Stochastics %K at buying indicates that the stock is to be held.

Most Popular